| Saturday, March 16, 2024 |
| 07:00 AM – 08:00 AM | Breakfast | |
| 08:00 AM – 08:10 AM | Introduction and Conference Goals | Michael S. Saag, MD |
| 08:10 AM – 08:40 AM | Antiretroviral Therapy: Starts, Switches and Rescues – Where Are We Now? | Roy M. Gulick, MD, MPH |
| 08:40 AM – 09:10 AM | Post-Conference Update from CROI 2024: “What Did I Miss?” | Constance A. Benson, MD |
| 09:10 AM – 09:35 AM | Panel Discussion / Questions and Answers | |
| 09:35 AM – 10:05 AM | The End of Oral? The Science and Future of Long-Acting Antivirals | Charles W. Flexner, MD |
| 10:05 AM – 10:30 AM | Panel Discussion / Questions and Answers | |
| 10:30 AM – 10:45 AM | Break | |
| 10:45 AM – 11:15 AM | Sexually Transmitted Infections: The Old & New | Khalil Georges Ghanem, MD, PhD |
| 11:15 AM – 11:45 AM | Pre-exposure Prophylaxis for HIV Infection: PrEP-aring for the Next Decade | Raphael Landovitz, MD, MSc |
| 11:45 AM – 12:10 PM | Panel Discussion / Questions and Answers | |
| 12:10 PM – 12:35 PM | Break | |
| 12:35 PM – 01:25 PM | Working Lunch - Case Presentations | Michael S. Saag, MD and faculty panel |
| 01:30 PM – 02:00 PM | Faculty Roundtable Session 1* | |
| 02:00 PM – 02:30 PM | Faculty Roundtable Session 2* (In-person attendees will have the opportunity to attend two of the three sessions) PrEP, Prevention and STI’s | Raphael Landovitz, MD, MSc Khalil Georges Ghanem, MD, PhD | Antiretroviral Therapy: Challenging Cases | Constance A. Benson, MD Glenn J. Treisman, MD, PhD | Emerging Advances in HIV Treatment | Charles W. Flexner, MD Roy M. Gulick, MD, MPH | |
|
Sunday, March 17, 2024 |
| 07:00 AM – 08:00 AM | Breakfast | |
| 08:00 AM – 08:10 AM | Introduction and Conference Goals | Mark S. Sulkowski, MD |
| 08:10 AM – 08:40 AM | Management Considerations for Hepatitis C | Susanna Naggie, MD, MHS |
| 08:40 AM – 09:10 AM | Management Considerations for Hepatitis B and D Infections: What’s New? | Shyamasundaran Kottilil, MD, PhD |
| 09:10 AM – 09:35 AM | Panel Discussion / Questions and Answers | |
| 09:35 AM – 10:05 AM | Management Considerations for Hepatitis B – HIV Coinfection | Debika Bhattacharya MD, MSc |
| 10:05 AM – 10:30 AM | Panel Discussion / Questions and Answers | |
| 10:30 AM – 10:45 AM | Break | |
| 10:45 AM – 11:15 AM | HIV and Metabolic Dysfunction-Associated Steatotic Liver Disease | Kenneth E. Sherman, MD, PhD |
| 11:15 AM – 11:45 AM | How to Manage in Patients with Substance Use Disorders? | Glenn J. Treisman, MD, PhD |
| 11:45 AM – 12:10 PM | Panel Discussion / Questions and Answers | |
| 12:10 PM – 12:35 PM | Break | |
| 12:35 PM – 01:25 PM | Working Lunch - Case Presentations | Mark S. Sulkowski, MD and faculty panel |
| 01:30 PM – 02:00 PM | Faculty Roundtable Session 1* | |
| 02:00 PM – 02:30 PM | Faculty Roundtable Session 2* (In-person attendees will have the opportunity to attend two of the three sessions) Hepatitis C: Challenging Cases | Susanna Naggie, MD, MHS Glenn J. Treisman, MD, PhD | Hepatitis B and D: More Questions and Answers | Debika Bhattacharya MD, MSc Shyamasundaran Kottilil, MD, PhD | Metabolic Dysfunction-Associated Steatotic Liver Disease | Mark S. Sulkowski, MD Kenneth E. Sherman, MD, PhD | |